Quest Diagnostics Inc.

Company Overview

Quest Diagnostics is the U.S.'s major independent clinical laboratory operator, offering diagnostic testing and risk assessment services. In 2022, it experienced growth in prenatal genetic testing and pharma services. With approximately 49,000 employees, Quest provides NGS-based assays through Illumina and Thermo Fisher agreements. The company specializes in gene-based esoteric testing for various diseases and has a key alliance with UnitedHealthcare. Quest acquired Blueprint Genetics, enhancing its NGS capabilities for rare diseases. QuestDirect allows consumer-initiated testing, and a coalition with Grail supports the development of NGS-based cancer screening tests.

Quest Diagnostics provides a range of diagnostic tests, including general health profile tests, Women’s Health Tests, Men’s Health Tests, Heart Health Tests, and Sexual Health Tests. With 50 million tests conducted annually, Quest serves patients of all ages.

Financial Highlights (FY 2024)

Company's Business Segments

• Diagnostic Information Services (DIS) business : Discovery, Technology development and clinical validation of diagnostic tests
• Diagnostic Solutions (DS) business : Risk assessment services business offers solutions for insurers, Healthcare IT businesses offers solutions for healthcare providers and payers